nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—CALM1—type 2 diabetes mellitus	0.173	0.398	CbGaD
Fluphenazine—ADRA2A—type 2 diabetes mellitus	0.0782	0.18	CbGaD
Fluphenazine—HTR2C—type 2 diabetes mellitus	0.072	0.166	CbGaD
Fluphenazine—CYP2E1—type 2 diabetes mellitus	0.0571	0.131	CbGaD
Fluphenazine—CYP1A2—type 2 diabetes mellitus	0.0543	0.125	CbGaD
Fluphenazine—HTR6—Bromocriptine—type 2 diabetes mellitus	0.0395	0.117	CbGbCtD
Fluphenazine—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0326	0.0969	CbGbCtD
Fluphenazine—DRD1—Bromocriptine—type 2 diabetes mellitus	0.0314	0.0933	CbGbCtD
Fluphenazine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.023	0.0683	CbGbCtD
Fluphenazine—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0216	0.0644	CbGbCtD
Fluphenazine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0207	0.0616	CbGbCtD
Fluphenazine—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0207	0.0616	CbGbCtD
Fluphenazine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0191	0.0567	CbGbCtD
Fluphenazine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0165	0.0491	CbGbCtD
Fluphenazine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0147	0.0437	CbGbCtD
Fluphenazine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0112	0.0334	CbGbCtD
Fluphenazine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0106	0.0316	CbGbCtD
Fluphenazine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.01	0.0298	CbGbCtD
Fluphenazine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00925	0.0275	CbGbCtD
Fluphenazine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00884	0.0263	CbGbCtD
Fluphenazine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00836	0.0249	CbGbCtD
Fluphenazine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0076	0.0226	CbGbCtD
Fluphenazine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00731	0.0217	CbGbCtD
Fluphenazine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00728	0.0217	CbGbCtD
Fluphenazine—CYP1A2—Losartan—type 2 diabetes mellitus	0.0057	0.0169	CbGbCtD
Fluphenazine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00545	0.0162	CbGbCtD
Fluphenazine—ABCB1—Losartan—type 2 diabetes mellitus	0.00498	0.0148	CbGbCtD
Fluphenazine—CALM1—sympathetic nervous system—type 2 diabetes mellitus	0.00239	0.0659	CbGeAlD
Fluphenazine—HTR2A—arteriole—type 2 diabetes mellitus	0.00228	0.063	CbGeAlD
Fluphenazine—CALM1—autonomic nervous system—type 2 diabetes mellitus	0.0016	0.0443	CbGeAlD
Fluphenazine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00145	0.0401	CbGeAlD
Fluphenazine—DRD1—nerve—type 2 diabetes mellitus	0.00141	0.0389	CbGeAlD
Fluphenazine—CALM2—peripheral nervous system—type 2 diabetes mellitus	0.00116	0.0321	CbGeAlD
Fluphenazine—CALM1—peripheral nervous system—type 2 diabetes mellitus	0.00116	0.0319	CbGeAlD
Fluphenazine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000977	0.027	CbGeAlD
Fluphenazine—CALM2—artery—type 2 diabetes mellitus	0.000914	0.0252	CbGeAlD
Fluphenazine—CALM1—artery—type 2 diabetes mellitus	0.000909	0.0251	CbGeAlD
Fluphenazine—CALM2—nerve—type 2 diabetes mellitus	0.000906	0.025	CbGeAlD
Fluphenazine—HTR2A—hindlimb—type 2 diabetes mellitus	0.000904	0.0249	CbGeAlD
Fluphenazine—CALM1—nerve—type 2 diabetes mellitus	0.000902	0.0249	CbGeAlD
Fluphenazine—DRD2—nerve—type 2 diabetes mellitus	0.000833	0.023	CbGeAlD
Fluphenazine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000829	0.0229	CbGeAlD
Fluphenazine—CALM2—endothelium—type 2 diabetes mellitus	0.000772	0.0213	CbGeAlD
Fluphenazine—CALM1—endothelium—type 2 diabetes mellitus	0.000768	0.0212	CbGeAlD
Fluphenazine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000705	0.0195	CbGeAlD
Fluphenazine—CALM3—islet of Langerhans—type 2 diabetes mellitus	0.000559	0.0154	CbGeAlD
Fluphenazine—HTR2A—artery—type 2 diabetes mellitus	0.000554	0.0153	CbGeAlD
Fluphenazine—HTR2A—nerve—type 2 diabetes mellitus	0.00055	0.0152	CbGeAlD
Fluphenazine—CALM3—retina—type 2 diabetes mellitus	0.000478	0.0132	CbGeAlD
Fluphenazine—HTR2A—endothelium—type 2 diabetes mellitus	0.000468	0.0129	CbGeAlD
Fluphenazine—CALM3—nephron tubule—type 2 diabetes mellitus	0.00045	0.0124	CbGeAlD
Fluphenazine—CALM2—islet of Langerhans—type 2 diabetes mellitus	0.000439	0.0121	CbGeAlD
Fluphenazine—CALM1—islet of Langerhans—type 2 diabetes mellitus	0.000437	0.0121	CbGeAlD
Fluphenazine—CALM3—pancreas—type 2 diabetes mellitus	0.000393	0.0108	CbGeAlD
Fluphenazine—CALM3—cortex of kidney—type 2 diabetes mellitus	0.000385	0.0106	CbGeAlD
Fluphenazine—CALM2—retina—type 2 diabetes mellitus	0.000375	0.0104	CbGeAlD
Fluphenazine—CALM1—retina—type 2 diabetes mellitus	0.000374	0.0103	CbGeAlD
Fluphenazine—CALM3—adipose tissue—type 2 diabetes mellitus	0.000357	0.00984	CbGeAlD
Fluphenazine—CALM2—nephron tubule—type 2 diabetes mellitus	0.000354	0.00976	CbGeAlD
Fluphenazine—CALM1—nephron tubule—type 2 diabetes mellitus	0.000352	0.00971	CbGeAlD
Fluphenazine—DRD2—retina—type 2 diabetes mellitus	0.000345	0.00952	CbGeAlD
Fluphenazine—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000323	0.00892	CbGeAlD
Fluphenazine—CALM2—cardiovascular system—type 2 diabetes mellitus	0.000318	0.00876	CbGeAlD
Fluphenazine—CALM1—cardiovascular system—type 2 diabetes mellitus	0.000316	0.00872	CbGeAlD
Fluphenazine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000313	0.00864	CbGeAlD
Fluphenazine—CALM2—kidney—type 2 diabetes mellitus	0.000311	0.00857	CbGeAlD
Fluphenazine—CALM1—kidney—type 2 diabetes mellitus	0.000309	0.00853	CbGeAlD
Fluphenazine—CALM2—pancreas—type 2 diabetes mellitus	0.000309	0.00852	CbGeAlD
Fluphenazine—CALM1—pancreas—type 2 diabetes mellitus	0.000307	0.00848	CbGeAlD
Fluphenazine—CALM2—cortex of kidney—type 2 diabetes mellitus	0.000303	0.00835	CbGeAlD
Fluphenazine—CALM1—cortex of kidney—type 2 diabetes mellitus	0.000301	0.00831	CbGeAlD
Fluphenazine—CALM2—adipose tissue—type 2 diabetes mellitus	0.00028	0.00773	CbGeAlD
Fluphenazine—CALM1—adipose tissue—type 2 diabetes mellitus	0.000279	0.00769	CbGeAlD
Fluphenazine—CALM3—liver—type 2 diabetes mellitus	0.00025	0.0069	CbGeAlD
Fluphenazine—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000247	0.00681	CbGeAlD
Fluphenazine—HTR2A—retina—type 2 diabetes mellitus	0.000228	0.00628	CbGeAlD
Fluphenazine—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000222	0.00611	CbGeAlD
Fluphenazine—ADRA2A—pancreas—type 2 diabetes mellitus	0.00022	0.00607	CbGeAlD
Fluphenazine—CYP2E1—kidney—type 2 diabetes mellitus	0.000217	0.00598	CbGeAlD
Fluphenazine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000216	0.00596	CbGeAlD
Fluphenazine—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000211	0.00583	CbGeAlD
Fluphenazine—Upper respiratory tract infection—Valsartan—type 2 diabetes mellitus	0.00021	0.00215	CcSEcCtD
Fluphenazine—Disturbance in sexual arousal—Losartan—type 2 diabetes mellitus	0.000209	0.00215	CcSEcCtD
Fluphenazine—Constipation—Repaglinide—type 2 diabetes mellitus	0.000209	0.00214	CcSEcCtD
Fluphenazine—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.000208	0.00213	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Orlistat—type 2 diabetes mellitus	0.000207	0.00212	CcSEcCtD
Fluphenazine—Leukopenia—Glimepiride—type 2 diabetes mellitus	0.000207	0.00212	CcSEcCtD
Fluphenazine—Photosensitivity—Ramipril—type 2 diabetes mellitus	0.000206	0.00211	CcSEcCtD
Fluphenazine—Polyuria—Ramipril—type 2 diabetes mellitus	0.000206	0.00211	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Valsartan—type 2 diabetes mellitus	0.000206	0.00211	CcSEcCtD
Fluphenazine—Hypertension—Pioglitazone—type 2 diabetes mellitus	0.000205	0.0021	CcSEcCtD
Fluphenazine—Agranulocytosis—Gliclazide—type 2 diabetes mellitus	0.000204	0.00209	CcSEcCtD
Fluphenazine—HRH1—adipose tissue—type 2 diabetes mellitus	0.000203	0.00561	CbGeAlD
Fluphenazine—Muscle spasms—Bromocriptine—type 2 diabetes mellitus	0.0002	0.00205	CcSEcCtD
Fluphenazine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.0002	0.00551	CbGeAlD
Fluphenazine—Pruritus—Nateglinide—type 2 diabetes mellitus	0.000199	0.00205	CcSEcCtD
Fluphenazine—Hypertension—Glimepiride—type 2 diabetes mellitus	0.000199	0.00204	CcSEcCtD
Fluphenazine—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000199	0.00204	CcSEcCtD
Fluphenazine—Hypertension—Sitagliptin—type 2 diabetes mellitus	0.000199	0.00204	CcSEcCtD
Fluphenazine—Nasal congestion—Ramipril—type 2 diabetes mellitus	0.000199	0.00204	CcSEcCtD
Fluphenazine—Constipation—Rosiglitazone—type 2 diabetes mellitus	0.000197	0.00202	CcSEcCtD
Fluphenazine—CALM2—liver—type 2 diabetes mellitus	0.000196	0.00542	CbGeAlD
Fluphenazine—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.000196	0.00201	CcSEcCtD
Fluphenazine—Renal failure acute—Ramipril—type 2 diabetes mellitus	0.000196	0.00201	CcSEcCtD
Fluphenazine—CALM1—liver—type 2 diabetes mellitus	0.000195	0.00539	CbGeAlD
Fluphenazine—Urticaria—Repaglinide—type 2 diabetes mellitus	0.000194	0.00199	CcSEcCtD
Fluphenazine—Dysphagia—Irbesartan—type 2 diabetes mellitus	0.000194	0.00199	CcSEcCtD
Fluphenazine—Asthma—Irbesartan—type 2 diabetes mellitus	0.000194	0.00199	CcSEcCtD
Fluphenazine—Oedema peripheral—Gliclazide—type 2 diabetes mellitus	0.000193	0.00198	CcSEcCtD
Fluphenazine—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.000193	0.00198	CcSEcCtD
Fluphenazine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000193	0.00531	CbGeAlD
Fluphenazine—Dry mouth—Glimepiride—type 2 diabetes mellitus	0.000192	0.00197	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Ramipril—type 2 diabetes mellitus	0.000192	0.00197	CcSEcCtD
Fluphenazine—Dry mouth—Sitagliptin—type 2 diabetes mellitus	0.000192	0.00196	CcSEcCtD
Fluphenazine—Agitation—Bromocriptine—type 2 diabetes mellitus	0.000191	0.00196	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Metformin—type 2 diabetes mellitus	0.000191	0.00196	CcSEcCtD
Fluphenazine—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000191	0.00195	CcSEcCtD
Fluphenazine—Headache—Tolazamide—type 2 diabetes mellitus	0.000191	0.00195	CcSEcCtD
Fluphenazine—Erythema—Glyburide—type 2 diabetes mellitus	0.00019	0.00195	CcSEcCtD
Fluphenazine—Headache—Linagliptin—type 2 diabetes mellitus	0.000189	0.00193	CcSEcCtD
Fluphenazine—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.000188	0.00193	CcSEcCtD
Fluphenazine—HTR2A—kidney—type 2 diabetes mellitus	0.000188	0.0052	CbGeAlD
Fluphenazine—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.000188	0.00193	CcSEcCtD
Fluphenazine—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.000188	0.00193	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Ramipril—type 2 diabetes mellitus	0.000187	0.00192	CcSEcCtD
Fluphenazine—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.000184	0.00189	CcSEcCtD
Fluphenazine—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.000183	0.00188	CcSEcCtD
Fluphenazine—Drowsiness—Metformin—type 2 diabetes mellitus	0.000183	0.00188	CcSEcCtD
Fluphenazine—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.000182	0.00187	CcSEcCtD
Fluphenazine—Nausea—Tolazamide—type 2 diabetes mellitus	0.000181	0.00185	CcSEcCtD
Fluphenazine—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000181	0.00185	CcSEcCtD
Fluphenazine—Eosinophilia—Losartan—type 2 diabetes mellitus	0.000181	0.00185	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Irbesartan—type 2 diabetes mellitus	0.00018	0.00185	CcSEcCtD
Fluphenazine—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.00018	0.00185	CcSEcCtD
Fluphenazine—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.00018	0.00184	CcSEcCtD
Fluphenazine—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00018	0.00184	CcSEcCtD
Fluphenazine—Somnolence—Glipizide—type 2 diabetes mellitus	0.00018	0.00184	CcSEcCtD
Fluphenazine—Disturbance in sexual arousal—Ramipril—type 2 diabetes mellitus	0.000179	0.00184	CcSEcCtD
Fluphenazine—Vision blurred—Glyburide—type 2 diabetes mellitus	0.000179	0.00184	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Irbesartan—type 2 diabetes mellitus	0.000177	0.00181	CcSEcCtD
Fluphenazine—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000176	0.00181	CcSEcCtD
Fluphenazine—Oedema peripheral—Orlistat—type 2 diabetes mellitus	0.000176	0.0018	CcSEcCtD
Fluphenazine—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.000176	0.0018	CcSEcCtD
Fluphenazine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000174	0.00481	CbGeAlD
Fluphenazine—Angioedema—Glyburide—type 2 diabetes mellitus	0.000174	0.00178	CcSEcCtD
Fluphenazine—Pneumonia—Irbesartan—type 2 diabetes mellitus	0.000174	0.00178	CcSEcCtD
Fluphenazine—Nausea—Acarbose—type 2 diabetes mellitus	0.000174	0.00178	CcSEcCtD
Fluphenazine—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.000173	0.00178	CcSEcCtD
Fluphenazine—Constipation—Glipizide—type 2 diabetes mellitus	0.000173	0.00177	CcSEcCtD
Fluphenazine—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000173	0.00177	CcSEcCtD
Fluphenazine—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000172	0.00177	CcSEcCtD
Fluphenazine—CYP2D6—kidney—type 2 diabetes mellitus	0.000172	0.00474	CbGeAlD
Fluphenazine—Erythema—Gliclazide—type 2 diabetes mellitus	0.000171	0.00175	CcSEcCtD
Fluphenazine—Leukopenia—Glyburide—type 2 diabetes mellitus	0.00017	0.00175	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Losartan—type 2 diabetes mellitus	0.000169	0.00174	CcSEcCtD
Fluphenazine—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000168	0.00172	CcSEcCtD
Fluphenazine—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000168	0.00172	CcSEcCtD
Fluphenazine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000167	0.00172	CcSEcCtD
Fluphenazine—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000167	0.00171	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	0.000166	0.00171	CcSEcCtD
Fluphenazine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000166	0.0017	CcSEcCtD
Fluphenazine—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000165	0.00169	CcSEcCtD
Fluphenazine—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000164	0.00168	CcSEcCtD
Fluphenazine—Pneumonia—Losartan—type 2 diabetes mellitus	0.000164	0.00168	CcSEcCtD
Fluphenazine—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000163	0.00167	CcSEcCtD
Fluphenazine—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000163	0.00167	CcSEcCtD
Fluphenazine—Oedema peripheral—Metformin—type 2 diabetes mellitus	0.000162	0.00166	CcSEcCtD
Fluphenazine—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000161	0.00165	CcSEcCtD
Fluphenazine—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000161	0.00165	CcSEcCtD
Fluphenazine—Urticaria—Glipizide—type 2 diabetes mellitus	0.00016	0.00164	CcSEcCtD
Fluphenazine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000159	0.00163	CcSEcCtD
Fluphenazine—Agitation—Gliclazide—type 2 diabetes mellitus	0.000157	0.00161	CcSEcCtD
Fluphenazine—Asthma—Ramipril—type 2 diabetes mellitus	0.000156	0.0016	CcSEcCtD
Fluphenazine—Dysphagia—Ramipril—type 2 diabetes mellitus	0.000156	0.0016	CcSEcCtD
Fluphenazine—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000156	0.0016	CcSEcCtD
Fluphenazine—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.000155	0.00159	CcSEcCtD
Fluphenazine—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000154	0.00158	CcSEcCtD
Fluphenazine—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000153	0.00157	CcSEcCtD
Fluphenazine—Headache—Repaglinide—type 2 diabetes mellitus	0.000153	0.00157	CcSEcCtD
Fluphenazine—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.000153	0.00157	CcSEcCtD
Fluphenazine—CYP1A2—liver—type 2 diabetes mellitus	0.000152	0.0042	CbGeAlD
Fluphenazine—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000152	0.00156	CcSEcCtD
Fluphenazine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000152	0.00155	CcSEcCtD
Fluphenazine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000151	0.00155	CcSEcCtD
Fluphenazine—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000151	0.00155	CcSEcCtD
Fluphenazine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00015	0.00153	CcSEcCtD
Fluphenazine—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000149	0.00153	CcSEcCtD
Fluphenazine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000149	0.00153	CcSEcCtD
Fluphenazine—ABCB1—retina—type 2 diabetes mellitus	0.000149	0.00412	CbGeAlD
Fluphenazine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000149	0.00153	CcSEcCtD
Fluphenazine—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000148	0.00152	CcSEcCtD
Fluphenazine—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000148	0.00152	CcSEcCtD
Fluphenazine—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000148	0.00152	CcSEcCtD
Fluphenazine—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000148	0.00151	CcSEcCtD
Fluphenazine—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000146	0.0015	CcSEcCtD
Fluphenazine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000145	0.00149	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.000145	0.00149	CcSEcCtD
Fluphenazine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000145	0.00149	CcSEcCtD
Fluphenazine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000145	0.00149	CcSEcCtD
Fluphenazine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000145	0.00148	CcSEcCtD
Fluphenazine—Angioedema—Valsartan—type 2 diabetes mellitus	0.000144	0.00147	CcSEcCtD
Fluphenazine—Erythema—Metformin—type 2 diabetes mellitus	0.000143	0.00147	CcSEcCtD
Fluphenazine—Pruritus—Glipizide—type 2 diabetes mellitus	0.000143	0.00146	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000143	0.00146	CcSEcCtD
Fluphenazine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000143	0.00146	CcSEcCtD
Fluphenazine—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000142	0.00146	CcSEcCtD
Fluphenazine—Angioedema—Orlistat—type 2 diabetes mellitus	0.000142	0.00145	CcSEcCtD
Fluphenazine—ABCB1—nephron tubule—type 2 diabetes mellitus	0.00014	0.00388	CbGeAlD
Fluphenazine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000139	0.00142	CcSEcCtD
Fluphenazine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000139	0.00142	CcSEcCtD
Fluphenazine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000138	0.00142	CcSEcCtD
Fluphenazine—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000138	0.00141	CcSEcCtD
Fluphenazine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000137	0.0014	CcSEcCtD
Fluphenazine—CYP2E1—liver—type 2 diabetes mellitus	0.000137	0.00378	CbGeAlD
Fluphenazine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000136	0.0014	CcSEcCtD
Fluphenazine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000136	0.00139	CcSEcCtD
Fluphenazine—Propericiazine—ADRA2A—type 2 diabetes mellitus	0.000136	0.0441	CrCbGaD
Fluphenazine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000135	0.00139	CcSEcCtD
Fluphenazine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000135	0.00138	CcSEcCtD
Fluphenazine—Erythema—Irbesartan—type 2 diabetes mellitus	0.000135	0.00138	CcSEcCtD
Fluphenazine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000135	0.00138	CcSEcCtD
Fluphenazine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000134	0.00138	CcSEcCtD
Fluphenazine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000133	0.00137	CcSEcCtD
Fluphenazine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000131	0.00134	CcSEcCtD
Fluphenazine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00013	0.00134	CcSEcCtD
Fluphenazine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.00013	0.00133	CcSEcCtD
Fluphenazine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.00013	0.00133	CcSEcCtD
Fluphenazine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000129	0.00133	CcSEcCtD
Fluphenazine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000128	0.00131	CcSEcCtD
Fluphenazine—Trifluoperazine—CALM1—type 2 diabetes mellitus	0.000128	0.0416	CrCbGaD
Fluphenazine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000127	0.0013	CcSEcCtD
Fluphenazine—Erythema—Losartan—type 2 diabetes mellitus	0.000127	0.0013	CcSEcCtD
Fluphenazine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000127	0.0013	CcSEcCtD
Fluphenazine—Headache—Glipizide—type 2 diabetes mellitus	0.000126	0.0013	CcSEcCtD
Fluphenazine—Perphenazine—CALM1—type 2 diabetes mellitus	0.000126	0.0412	CrCbGaD
Fluphenazine—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000126	0.00348	CbGeAlD
Fluphenazine—Cyamemazine—HTR2C—type 2 diabetes mellitus	0.000125	0.0406	CrCbGaD
Fluphenazine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000125	0.00128	CcSEcCtD
Fluphenazine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000124	0.00128	CcSEcCtD
Fluphenazine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000124	0.00127	CcSEcCtD
Fluphenazine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000124	0.00127	CcSEcCtD
Fluphenazine—Hypertension—Metformin—type 2 diabetes mellitus	0.000124	0.00127	CcSEcCtD
Fluphenazine—ABCB1—kidney—type 2 diabetes mellitus	0.000123	0.00341	CbGeAlD
Fluphenazine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000123	0.00127	CcSEcCtD
Fluphenazine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000123	0.00126	CcSEcCtD
Fluphenazine—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000123	0.00126	CcSEcCtD
Fluphenazine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000123	0.00126	CcSEcCtD
Fluphenazine—ABCB1—pancreas—type 2 diabetes mellitus	0.000123	0.00338	CbGeAlD
Fluphenazine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000122	0.00125	CcSEcCtD
Fluphenazine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000121	0.00124	CcSEcCtD
Fluphenazine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000121	0.00124	CcSEcCtD
Fluphenazine—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.00012	0.00332	CbGeAlD
Fluphenazine—Nausea—Glipizide—type 2 diabetes mellitus	0.00012	0.00123	CcSEcCtD
Fluphenazine—Hypotension—Valsartan—type 2 diabetes mellitus	0.00012	0.00123	CcSEcCtD
Fluphenazine—Vision blurred—Losartan—type 2 diabetes mellitus	0.00012	0.00123	CcSEcCtD
Fluphenazine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000119	0.00122	CcSEcCtD
Fluphenazine—HTR2A—liver—type 2 diabetes mellitus	0.000119	0.00329	CbGeAlD
Fluphenazine—Headache—Glimepiride—type 2 diabetes mellitus	0.000118	0.00121	CcSEcCtD
Fluphenazine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000118	0.00121	CcSEcCtD
Fluphenazine—Agitation—Losartan—type 2 diabetes mellitus	0.000117	0.0012	CcSEcCtD
Fluphenazine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000117	0.00119	CcSEcCtD
Fluphenazine—Angioedema—Losartan—type 2 diabetes mellitus	0.000116	0.00119	CcSEcCtD
Fluphenazine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000114	0.00117	CcSEcCtD
Fluphenazine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000114	0.00117	CcSEcCtD
Fluphenazine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000114	0.00117	CcSEcCtD
Fluphenazine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000114	0.00117	CcSEcCtD
Fluphenazine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000113	0.00116	CcSEcCtD
Fluphenazine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000112	0.00115	CcSEcCtD
Fluphenazine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000112	0.00115	CcSEcCtD
Fluphenazine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000112	0.00114	CcSEcCtD
Fluphenazine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000111	0.00114	CcSEcCtD
Fluphenazine—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000111	0.00307	CbGeAlD
Fluphenazine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000111	0.00114	CcSEcCtD
Fluphenazine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00011	0.00113	CcSEcCtD
Fluphenazine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00011	0.00113	CcSEcCtD
Fluphenazine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00011	0.00113	CcSEcCtD
Fluphenazine—Pruritus—Glyburide—type 2 diabetes mellitus	0.00011	0.00113	CcSEcCtD
Fluphenazine—Constipation—Valsartan—type 2 diabetes mellitus	0.00011	0.00112	CcSEcCtD
Fluphenazine—Hypotension—Metformin—type 2 diabetes mellitus	0.000109	0.00112	CcSEcCtD
Fluphenazine—Erythema—Ramipril—type 2 diabetes mellitus	0.000109	0.00112	CcSEcCtD
Fluphenazine—CYP2D6—liver—type 2 diabetes mellitus	0.000108	0.00299	CbGeAlD
Fluphenazine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000108	0.0011	CcSEcCtD
Fluphenazine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000107	0.0011	CcSEcCtD
Fluphenazine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000106	0.00109	CcSEcCtD
Fluphenazine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000106	0.00108	CcSEcCtD
Fluphenazine—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000105	0.00107	CcSEcCtD
Fluphenazine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000104	0.00107	CcSEcCtD
Fluphenazine—Somnolence—Metformin—type 2 diabetes mellitus	0.000104	0.00106	CcSEcCtD
Fluphenazine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000104	0.00106	CcSEcCtD
Fluphenazine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000103	0.00106	CcSEcCtD
Fluphenazine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000103	0.00105	CcSEcCtD
Fluphenazine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000102	0.00104	CcSEcCtD
Fluphenazine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000101	0.00104	CcSEcCtD
Fluphenazine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000101	0.00104	CcSEcCtD
Fluphenazine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000101	0.00104	CcSEcCtD
Fluphenazine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000101	0.00103	CcSEcCtD
Fluphenazine—Chlorpromazine—CALM1—type 2 diabetes mellitus	0.0001	0.0327	CrCbGaD
Fluphenazine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.0001	0.00103	CcSEcCtD
Fluphenazine—Agitation—Ramipril—type 2 diabetes mellitus	0.0001	0.00103	CcSEcCtD
Fluphenazine—Constipation—Metformin—type 2 diabetes mellitus	9.98e-05	0.00102	CcSEcCtD
Fluphenazine—Angioedema—Ramipril—type 2 diabetes mellitus	9.95e-05	0.00102	CcSEcCtD
Fluphenazine—Pruritus—Gliclazide—type 2 diabetes mellitus	9.87e-05	0.00101	CcSEcCtD
Fluphenazine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	9.82e-05	0.00101	CcSEcCtD
Fluphenazine—Somnolence—Irbesartan—type 2 diabetes mellitus	9.79e-05	0.001	CcSEcCtD
Fluphenazine—Leukopenia—Ramipril—type 2 diabetes mellitus	9.75e-05	0.001	CcSEcCtD
Fluphenazine—Headache—Glyburide—type 2 diabetes mellitus	9.74e-05	0.000998	CcSEcCtD
Fluphenazine—Zuclopenthixol—ADRA2A—type 2 diabetes mellitus	9.71e-05	0.0316	CrCbGaD
Fluphenazine—Hypotension—Losartan—type 2 diabetes mellitus	9.69e-05	0.000993	CcSEcCtD
Fluphenazine—Nefazodone—ADRA2A—type 2 diabetes mellitus	9.66e-05	0.0314	CrCbGaD
Fluphenazine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	9.58e-05	0.000982	CcSEcCtD
Fluphenazine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	9.45e-05	0.000968	CcSEcCtD
Fluphenazine—Constipation—Irbesartan—type 2 diabetes mellitus	9.42e-05	0.000966	CcSEcCtD
Fluphenazine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	9.33e-05	0.000957	CcSEcCtD
Fluphenazine—Urticaria—Metformin—type 2 diabetes mellitus	9.27e-05	0.000951	CcSEcCtD
Fluphenazine—Dyspnoea—Losartan—type 2 diabetes mellitus	9.24e-05	0.000948	CcSEcCtD
Fluphenazine—Nausea—Glyburide—type 2 diabetes mellitus	9.23e-05	0.000946	CcSEcCtD
Fluphenazine—Somnolence—Losartan—type 2 diabetes mellitus	9.22e-05	0.000945	CcSEcCtD
Fluphenazine—Pruritus—Valsartan—type 2 diabetes mellitus	9.07e-05	0.00093	CcSEcCtD
Fluphenazine—Dry mouth—Ramipril—type 2 diabetes mellitus	9.07e-05	0.00093	CcSEcCtD
Fluphenazine—Decreased appetite—Losartan—type 2 diabetes mellitus	9.01e-05	0.000924	CcSEcCtD
Fluphenazine—Pruritus—Orlistat—type 2 diabetes mellitus	8.96e-05	0.000919	CcSEcCtD
Fluphenazine—Trazodone—ADRA2A—type 2 diabetes mellitus	8.94e-05	0.0291	CrCbGaD
Fluphenazine—Nefazodone—HTR2C—type 2 diabetes mellitus	8.89e-05	0.0289	CrCbGaD
Fluphenazine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	8.89e-05	0.000912	CcSEcCtD
Fluphenazine—Constipation—Losartan—type 2 diabetes mellitus	8.87e-05	0.000909	CcSEcCtD
Fluphenazine—Urticaria—Irbesartan—type 2 diabetes mellitus	8.75e-05	0.000897	CcSEcCtD
Fluphenazine—Headache—Gliclazide—type 2 diabetes mellitus	8.74e-05	0.000896	CcSEcCtD
Fluphenazine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.71e-05	0.000893	CcSEcCtD
Fluphenazine—Tachycardia—Ramipril—type 2 diabetes mellitus	8.68e-05	0.00089	CcSEcCtD
Fluphenazine—Skin disorder—Ramipril—type 2 diabetes mellitus	8.64e-05	0.000885	CcSEcCtD
Fluphenazine—Thiothixene—ADRA2A—type 2 diabetes mellitus	8.37e-05	0.0273	CrCbGaD
Fluphenazine—Hypotension—Ramipril—type 2 diabetes mellitus	8.31e-05	0.000852	CcSEcCtD
Fluphenazine—Nausea—Gliclazide—type 2 diabetes mellitus	8.29e-05	0.00085	CcSEcCtD
Fluphenazine—Pruritus—Metformin—type 2 diabetes mellitus	8.26e-05	0.000847	CcSEcCtD
Fluphenazine—Urticaria—Losartan—type 2 diabetes mellitus	8.24e-05	0.000845	CcSEcCtD
Fluphenazine—Trazodone—HTR2C—type 2 diabetes mellitus	8.23e-05	0.0268	CrCbGaD
Fluphenazine—Body temperature increased—Losartan—type 2 diabetes mellitus	8.2e-05	0.00084	CcSEcCtD
Fluphenazine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	8.12e-05	0.000832	CcSEcCtD
Fluphenazine—Headache—Valsartan—type 2 diabetes mellitus	8.03e-05	0.000823	CcSEcCtD
Fluphenazine—Headache—Orlistat—type 2 diabetes mellitus	7.94e-05	0.000814	CcSEcCtD
Fluphenazine—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.93e-05	0.000813	CcSEcCtD
Fluphenazine—Somnolence—Ramipril—type 2 diabetes mellitus	7.9e-05	0.00081	CcSEcCtD
Fluphenazine—ABCB1—liver—type 2 diabetes mellitus	7.8e-05	0.00215	CbGeAlD
Fluphenazine—Pruritus—Irbesartan—type 2 diabetes mellitus	7.79e-05	0.000799	CcSEcCtD
Fluphenazine—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.73e-05	0.000792	CcSEcCtD
Fluphenazine—Thiothixene—HTR2C—type 2 diabetes mellitus	7.71e-05	0.0251	CrCbGaD
Fluphenazine—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.64e-05	0.000783	CcSEcCtD
Fluphenazine—Nausea—Valsartan—type 2 diabetes mellitus	7.62e-05	0.000781	CcSEcCtD
Fluphenazine—Mesoridazine—HTR2C—type 2 diabetes mellitus	7.61e-05	0.0248	CrCbGaD
Fluphenazine—Constipation—Ramipril—type 2 diabetes mellitus	7.6e-05	0.000779	CcSEcCtD
Fluphenazine—Nausea—Orlistat—type 2 diabetes mellitus	7.52e-05	0.000771	CcSEcCtD
Fluphenazine—Prochlorperazine—HTR2C—type 2 diabetes mellitus	7.37e-05	0.024	CrCbGaD
Fluphenazine—Pruritus—Losartan—type 2 diabetes mellitus	7.34e-05	0.000752	CcSEcCtD
Fluphenazine—Headache—Metformin—type 2 diabetes mellitus	7.31e-05	0.00075	CcSEcCtD
Fluphenazine—Urticaria—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000724	CcSEcCtD
Fluphenazine—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.03e-05	0.000721	CcSEcCtD
Fluphenazine—Nausea—Metformin—type 2 diabetes mellitus	6.93e-05	0.000711	CcSEcCtD
Fluphenazine—Headache—Irbesartan—type 2 diabetes mellitus	6.9e-05	0.000708	CcSEcCtD
Fluphenazine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.55e-05	0.000672	CcSEcCtD
Fluphenazine—Nausea—Irbesartan—type 2 diabetes mellitus	6.54e-05	0.000671	CcSEcCtD
Fluphenazine—Headache—Losartan—type 2 diabetes mellitus	6.5e-05	0.000666	CcSEcCtD
Fluphenazine—Propiomazine—HTR2C—type 2 diabetes mellitus	6.41e-05	0.0209	CrCbGaD
Fluphenazine—Pruritus—Ramipril—type 2 diabetes mellitus	6.29e-05	0.000645	CcSEcCtD
Fluphenazine—Thioridazine—ADRA2A—type 2 diabetes mellitus	6.24e-05	0.0203	CrCbGaD
Fluphenazine—Nausea—Losartan—type 2 diabetes mellitus	6.16e-05	0.000631	CcSEcCtD
Fluphenazine—Methotrimeprazine—ADRA2A—type 2 diabetes mellitus	5.95e-05	0.0194	CrCbGaD
Fluphenazine—Thiothixene—CYP1A2—type 2 diabetes mellitus	5.82e-05	0.0189	CrCbGaD
Fluphenazine—Pipotiazine—CYP1A2—type 2 diabetes mellitus	5.82e-05	0.0189	CrCbGaD
Fluphenazine—Thioridazine—HTR2C—type 2 diabetes mellitus	5.74e-05	0.0187	CrCbGaD
Fluphenazine—Perphenazine—ADRA2A—type 2 diabetes mellitus	5.72e-05	0.0186	CrCbGaD
Fluphenazine—Quetiapine—ADRA2A—type 2 diabetes mellitus	5.61e-05	0.0183	CrCbGaD
Fluphenazine—Headache—Ramipril—type 2 diabetes mellitus	5.57e-05	0.000571	CcSEcCtD
Fluphenazine—Methotrimeprazine—HTR2C—type 2 diabetes mellitus	5.48e-05	0.0178	CrCbGaD
Fluphenazine—Mequitazine—CYP3A4—type 2 diabetes mellitus	5.41e-05	0.0176	CrCbGaD
Fluphenazine—Trifluoperazine—HTR2C—type 2 diabetes mellitus	5.33e-05	0.0173	CrCbGaD
Fluphenazine—Nausea—Ramipril—type 2 diabetes mellitus	5.28e-05	0.000541	CcSEcCtD
Fluphenazine—Perphenazine—HTR2C—type 2 diabetes mellitus	5.27e-05	0.0172	CrCbGaD
Fluphenazine—Quetiapine—HTR2C—type 2 diabetes mellitus	5.17e-05	0.0168	CrCbGaD
Fluphenazine—Promazine—ADRA2A—type 2 diabetes mellitus	5.16e-05	0.0168	CrCbGaD
Fluphenazine—Promazine—HTR2C—type 2 diabetes mellitus	4.75e-05	0.0155	CrCbGaD
Fluphenazine—Thioridazine—CYP2E1—type 2 diabetes mellitus	4.55e-05	0.0148	CrCbGaD
Fluphenazine—Chlorpromazine—ADRA2A—type 2 diabetes mellitus	4.54e-05	0.0148	CrCbGaD
Fluphenazine—Nefazodone—CYP3A4—type 2 diabetes mellitus	4.44e-05	0.0145	CrCbGaD
Fluphenazine—Methotrimeprazine—CYP2E1—type 2 diabetes mellitus	4.35e-05	0.0142	CrCbGaD
Fluphenazine—Thioridazine—CYP1A2—type 2 diabetes mellitus	4.33e-05	0.0141	CrCbGaD
Fluphenazine—Chlorpromazine—HTR2C—type 2 diabetes mellitus	4.18e-05	0.0136	CrCbGaD
Fluphenazine—Methotrimeprazine—CYP1A2—type 2 diabetes mellitus	4.14e-05	0.0135	CrCbGaD
Fluphenazine—Trazodone—CYP3A4—type 2 diabetes mellitus	4.11e-05	0.0134	CrCbGaD
Fluphenazine—Trifluoperazine—CYP1A2—type 2 diabetes mellitus	4.02e-05	0.0131	CrCbGaD
Fluphenazine—Perphenazine—CYP1A2—type 2 diabetes mellitus	3.98e-05	0.0129	CrCbGaD
Fluphenazine—Pipotiazine—CYP3A4—type 2 diabetes mellitus	3.85e-05	0.0125	CrCbGaD
Fluphenazine—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	3.68e-05	0.012	CrCbGaD
Fluphenazine—Promazine—CYP1A2—type 2 diabetes mellitus	3.58e-05	0.0117	CrCbGaD
Fluphenazine—Acepromazine—ALB—type 2 diabetes mellitus	3.49e-05	0.0114	CrCbGaD
Fluphenazine—Thioproperazine—ALB—type 2 diabetes mellitus	3.41e-05	0.0111	CrCbGaD
Fluphenazine—Thiothixene—ALB—type 2 diabetes mellitus	3.36e-05	0.0109	CrCbGaD
Fluphenazine—Pipotiazine—ALB—type 2 diabetes mellitus	3.36e-05	0.0109	CrCbGaD
Fluphenazine—Chlorpromazine—CYP2E1—type 2 diabetes mellitus	3.32e-05	0.0108	CrCbGaD
Fluphenazine—Chlorpromazine—CYP1A2—type 2 diabetes mellitus	3.15e-05	0.0103	CrCbGaD
Fluphenazine—Perphenazine—CYP3A4—type 2 diabetes mellitus	2.63e-05	0.00857	CrCbGaD
Fluphenazine—Quetiapine—CYP3A4—type 2 diabetes mellitus	2.58e-05	0.0084	CrCbGaD
Fluphenazine—Promazine—CYP3A4—type 2 diabetes mellitus	2.37e-05	0.00772	CrCbGaD
Fluphenazine—Chlorpromazine—CYP3A4—type 2 diabetes mellitus	2.09e-05	0.0068	CrCbGaD
Fluphenazine—Chlorpromazine—ALB—type 2 diabetes mellitus	1.82e-05	0.00593	CrCbGaD
Fluphenazine—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.51e-06	1.63e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	1.51e-06	1.63e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.51e-06	1.63e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.51e-06	1.63e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.51e-06	1.63e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.51e-06	1.63e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.5e-06	1.63e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.5e-06	1.63e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—NOS3—type 2 diabetes mellitus	1.5e-06	1.62e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.5e-06	1.62e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PIK3R1—type 2 diabetes mellitus	1.5e-06	1.62e-05	CbGpPWpGaD
Fluphenazine—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.5e-06	1.62e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.49e-06	1.61e-05	CbGpPWpGaD
Fluphenazine—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.49e-06	1.61e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—NFKB1—type 2 diabetes mellitus	1.49e-06	1.61e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—NFKB1—type 2 diabetes mellitus	1.49e-06	1.61e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.48e-06	1.61e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.48e-06	1.6e-05	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—AKT1—type 2 diabetes mellitus	1.48e-06	1.6e-05	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—AKT1—type 2 diabetes mellitus	1.48e-06	1.6e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.48e-06	1.6e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.47e-06	1.59e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.47e-06	1.59e-05	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—AKT1—type 2 diabetes mellitus	1.47e-06	1.59e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.47e-06	1.59e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.46e-06	1.58e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.46e-06	1.58e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.45e-06	1.57e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.45e-06	1.57e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—NOS3—type 2 diabetes mellitus	1.45e-06	1.57e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—NOS3—type 2 diabetes mellitus	1.45e-06	1.57e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.44e-06	1.56e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.44e-06	1.56e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.44e-06	1.56e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.44e-06	1.56e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.44e-06	1.56e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.44e-06	1.56e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—SRC—type 2 diabetes mellitus	1.43e-06	1.55e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.43e-06	1.55e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—INS—type 2 diabetes mellitus	1.43e-06	1.55e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.43e-06	1.55e-05	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—AKT1—type 2 diabetes mellitus	1.42e-06	1.54e-05	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—AKT1—type 2 diabetes mellitus	1.42e-06	1.54e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.42e-06	1.54e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.42e-06	1.53e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.41e-06	1.53e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.41e-06	1.53e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.41e-06	1.52e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.41e-06	1.52e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.4e-06	1.52e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.39e-06	1.51e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.39e-06	1.5e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—SRC—type 2 diabetes mellitus	1.39e-06	1.5e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—SRC—type 2 diabetes mellitus	1.39e-06	1.5e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—INS—type 2 diabetes mellitus	1.38e-06	1.5e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—INS—type 2 diabetes mellitus	1.38e-06	1.5e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.38e-06	1.5e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.38e-06	1.49e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.38e-06	1.49e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	1.38e-06	1.49e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.38e-06	1.49e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.37e-06	1.49e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.37e-06	1.49e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.37e-06	1.48e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PTGS2—type 2 diabetes mellitus	1.37e-06	1.48e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.36e-06	1.47e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.36e-06	1.47e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.36e-06	1.47e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.35e-06	1.47e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.35e-06	1.46e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.34e-06	1.45e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.34e-06	1.45e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.34e-06	1.45e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.34e-06	1.45e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.34e-06	1.45e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.33e-06	1.44e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.33e-06	1.44e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PTGS2—type 2 diabetes mellitus	1.33e-06	1.43e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PTGS2—type 2 diabetes mellitus	1.33e-06	1.43e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.33e-06	1.43e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—SRC—type 2 diabetes mellitus	1.32e-06	1.43e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.32e-06	1.43e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.32e-06	1.43e-05	CbGpPWpGaD
Fluphenazine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.31e-06	1.42e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.31e-06	1.42e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.3e-06	1.41e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.3e-06	1.41e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.3e-06	1.41e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.3e-06	1.4e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.29e-06	1.4e-05	CbGpPWpGaD
Fluphenazine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.29e-06	1.4e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.29e-06	1.4e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.29e-06	1.4e-05	CbGpPWpGaD
Fluphenazine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.29e-06	1.4e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.29e-06	1.39e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.28e-06	1.39e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—SRC—type 2 diabetes mellitus	1.28e-06	1.39e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—SRC—type 2 diabetes mellitus	1.28e-06	1.39e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.28e-06	1.38e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.28e-06	1.38e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.27e-06	1.38e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.27e-06	1.37e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.27e-06	1.37e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.27e-06	1.37e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.26e-06	1.36e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—EGFR—type 2 diabetes mellitus	1.26e-06	1.36e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.25e-06	1.36e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.25e-06	1.36e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.25e-06	1.36e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.24e-06	1.35e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.24e-06	1.34e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.23e-06	1.33e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.22e-06	1.32e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.22e-06	1.32e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—EGFR—type 2 diabetes mellitus	1.22e-06	1.32e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—EGFR—type 2 diabetes mellitus	1.22e-06	1.32e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.21e-06	1.31e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.21e-06	1.31e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.21e-06	1.31e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.21e-06	1.31e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.21e-06	1.31e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.21e-06	1.31e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.21e-06	1.31e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.21e-06	1.31e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.2e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.2e-06	1.29e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.2e-06	1.29e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.19e-06	1.29e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.19e-06	1.28e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—TGFB1—type 2 diabetes mellitus	1.18e-06	1.28e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—RELA—type 2 diabetes mellitus	1.18e-06	1.28e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.18e-06	1.27e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	1.18e-06	1.27e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.17e-06	1.27e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.17e-06	1.27e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.17e-06	1.26e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—EGFR—type 2 diabetes mellitus	1.16e-06	1.26e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.16e-06	1.25e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.16e-06	1.25e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.15e-06	1.24e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—TGFB1—type 2 diabetes mellitus	1.14e-06	1.24e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—TGFB1—type 2 diabetes mellitus	1.14e-06	1.24e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.14e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.14e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.14e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.14e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.13e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.13e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.13e-06	1.22e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—EGFR—type 2 diabetes mellitus	1.12e-06	1.21e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—EGFR—type 2 diabetes mellitus	1.12e-06	1.21e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.12e-06	1.21e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.12e-06	1.21e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.11e-06	1.21e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.11e-06	1.2e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.1e-06	1.19e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.09e-06	1.18e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.09e-06	1.18e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.09e-06	1.17e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.09e-06	1.17e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.07e-06	1.16e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.07e-06	1.16e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.07e-06	1.16e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.06e-06	1.15e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.06e-06	1.14e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.05e-06	1.14e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.04e-06	1.12e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.03e-06	1.12e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.03e-06	1.11e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.03e-06	1.11e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.02e-06	1.11e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.02e-06	1.11e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.02e-06	1.1e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.01e-06	1.1e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.01e-06	1.1e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.01e-06	1.09e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	9.99e-07	1.08e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.98e-07	1.08e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.96e-07	1.08e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.95e-07	1.08e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.95e-07	1.08e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.9e-07	1.07e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	9.79e-07	1.06e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.79e-07	1.06e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.77e-07	1.06e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.75e-07	1.06e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.73e-07	1.05e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.73e-07	1.05e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL6—type 2 diabetes mellitus	9.66e-07	1.05e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.62e-07	1.04e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.62e-07	1.04e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	9.48e-07	1.03e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.43e-07	1.02e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.43e-07	1.02e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL6—type 2 diabetes mellitus	9.34e-07	1.01e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL6—type 2 diabetes mellitus	9.34e-07	1.01e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.34e-07	1.01e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—SRC—type 2 diabetes mellitus	9.27e-07	1e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.22e-07	9.97e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.08e-07	9.83e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	9.07e-07	9.81e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	9.07e-07	9.81e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.03e-07	9.77e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—SRC—type 2 diabetes mellitus	8.97e-07	9.7e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—SRC—type 2 diabetes mellitus	8.97e-07	9.7e-06	CbGpPWpGaD
Fluphenazine—CALM3—Disease—IL6—type 2 diabetes mellitus	8.92e-07	9.65e-06	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—AKT1—type 2 diabetes mellitus	8.91e-07	9.64e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.91e-07	9.64e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.73e-07	9.45e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.73e-07	9.45e-06	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	8.71e-07	9.42e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	8.66e-07	9.37e-06	CbGpPWpGaD
Fluphenazine—CALM2—Disease—IL6—type 2 diabetes mellitus	8.63e-07	9.33e-06	CbGpPWpGaD
Fluphenazine—CALM1—Disease—IL6—type 2 diabetes mellitus	8.63e-07	9.33e-06	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—AKT1—type 2 diabetes mellitus	8.62e-07	9.33e-06	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—AKT1—type 2 diabetes mellitus	8.62e-07	9.33e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	8.29e-07	8.97e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.29e-07	8.97e-06	CbGpPWpGaD
Fluphenazine—CALM3—Disease—AKT1—type 2 diabetes mellitus	8.23e-07	8.9e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.13e-07	8.79e-06	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.03e-07	8.69e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.02e-07	8.67e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.02e-07	8.67e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.99e-07	8.65e-06	CbGpPWpGaD
Fluphenazine—CALM1—Disease—AKT1—type 2 diabetes mellitus	7.96e-07	8.61e-06	CbGpPWpGaD
Fluphenazine—CALM2—Disease—AKT1—type 2 diabetes mellitus	7.96e-07	8.61e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.86e-07	8.5e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.86e-07	8.5e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	7.65e-07	8.27e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	7.55e-07	8.17e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.52e-07	8.14e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	7.51e-07	8.12e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.05e-07	7.63e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.94e-07	7.51e-06	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	6.93e-07	7.5e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.92e-07	7.49e-06	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—AKT1—type 2 diabetes mellitus	6.89e-07	7.45e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.84e-07	7.4e-06	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—AKT1—type 2 diabetes mellitus	6.66e-07	7.21e-06	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—AKT1—type 2 diabetes mellitus	6.66e-07	7.21e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.31e-07	6.83e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL6—type 2 diabetes mellitus	6.24e-07	6.76e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL6—type 2 diabetes mellitus	6.04e-07	6.54e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL6—type 2 diabetes mellitus	6.04e-07	6.54e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.76e-07	6.23e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.57e-07	6.03e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.57e-07	6.03e-06	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	5.22e-07	5.65e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	4.92e-07	5.32e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	4.17e-07	4.51e-06	CbGpPWpGaD
